LON/0R0O (LON/0R0O)

London Stock Exchange: LON/0R0O · USD

$413

+1.68 (+0.4%)· Recorded snapshot

Market cap	278.4B
Revenue (ttm)	339B
Net income (ttm)	12B
EPS (ttm)	$13.2
P/E (trailing)	23.6x
P/E (forward)	18.3x
Dividend	$6.98 (2.25%)
Volume	4,348
Beta	0.61

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 339B
Net income (ttm): 12B
EPS (ttm): $13.2
P/E (trailing): 23.6x
P/E (forward): 18.3x
Market cap: 278.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.3

P25 n/aP50 n/aP75 n/a

Trailing P/E23.6

P25 n/aP50 n/aP75 n/a

ROE15.8

P25 n/aP50 n/aP75 n/a

ROIC12.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All LON/0R0O indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United States
Country code	UK
Earnings date	2026-10-13
Employees	390,000
Employees change	-40,000
Employees growth	-9.09%
Enterprise value	$315.9B
Exchange	London Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1974
Industry	Healthcare Plans
Is primary listing	No
ISIN number	US91324P1021
Last earnings date	2026-10-13
Last refreshed	2026-10-28
Market cap	$278.4B
Next earnings date	2027-01-12
Price	$412.67
Price currency	USD
Sector	Healthcare
SIC code	6324
Stock price date	2026-10-28
Symbol	lon/0R0O
Website	https://www.unitedhealthgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	22.39x
Average P/E ratio (3Y)	25.01x
Average P/E ratio (5Y)	24.72x
Earnings yield	4.24%
EV/Earnings	26.27x
EV/EBIT	15.88x
EV/EBITDA	13.71x
EV/FCF	18.28x
EV/Sales	0.93x
FCF / EV yield	5.47%
FCF yield	6.21%
Forward P/E	18.28x
Graham number	217.19437
Graham upside	-47.15%
Lynch fair value	$88.82
Lynch upside	-78.39%
P/(FCF - SBC) ratio	16.85x
P/(OCF - SBC) ratio	14.6x
P/B ratio	3.48x
P/E ratio	23.59x
P/FCF ratio	16.1x
P/OCF ratio	14.03x
P/S ratio	0.82x
Price / tangible book value	3.53x
Price/EBITDA ratio	12.72x
Sector forward P/E	14.52x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	5.85%
EBITDA margin	6.42%
Effective tax rate	15.54%
FCF margin	5.08%
Gross margin	20.05%
Operating margin	5.85%
Pretax margin	4.38%
Profit margin	3.53%
Profit per employee	$30,678
Profitable quarters	9
Profitable years	27
Revenue per employee	$869,225
ROA	5.24%
ROA (5Y)	6.86%
ROCE	13.38%
ROE	15.77%
ROE (5Y)	20.42%
ROIC	12.39%
ROIC (5Y)	14.86%
SBC / revenue	0.23%
Tax / revenue	0.68%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-8.96%
EPS growth (Q)	75.93%
EPS growth (QoQ)	-24.56%
EPS growth 10Y	9.96%
EPS growth 3Y	-8.76%
EPS growth 5Y	1.66%
EPS growth quarters	2
EPS growth years	0
FCF growth	31.4%
FCF growth (Q)	-15.65%
FCF growth (QoQ)	-58.41%
FCF growth 3Y	-4.78%
FCF growth 5Y	-0.06%
Net income growth	-9.69%
Net income growth (Q)	75.04%
Net income growth (QoQ)	-25.05%
Net income growth 3Y	-9.86%
Net income growth 5Y	0.59%
Net income growth quarters	1
Net income growth years	0
OCF growth	24.99%
OCF growth (Q)	-13.83%
OCF growth (QoQ)	-53.65%
OCF growth 10Y	5.94%
OCF growth 3Y	-4.13%
OCF growth 5Y	0.76%
Revenue growth	3.42%
Revenue growth (Q)	-0.41%
Revenue growth (QoQ)	0.59%
Revenue growth 10Y	9.54%
Revenue growth 3Y	7.73%
Revenue growth 5Y	10.01%
Revenue growth quarters	126
Revenue growth years	33

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-2.5B
EBIT	$19.8B
EBITDA	$21.8B
EPS	$13.17
Financing cash flow	$-12.1B
Free cash flow	$17.2B
Free cash flow minus SBC	$16.4B
Gross profit	$68B
Income taxes	$2.3B
Investing cash flow	$-8.6B
Net borrowing	$-3.6B
Net cash flow	$-1B
Net income	$12B
Operating cash flow minus SBC	$19B
Operating income	$19.8B
Revenue	$339B
Stock-based compensation	$767.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$86.95
Debt / EBITDA	2.44
Debt / equity	0.7
Debt / FCF	3.26
Interest coverage	6.84
Net cash (debt)	$-36.5B
Net cash / market cap	-13.19%
Net debt / EBITDA	1.68
Net debt / equity	0.46
Net debt / FCF	2.12
Piotroski F-Score	6
Shareholders' equity	$79.5B
Tangible book value	$78.4B
Tangible book value per share	$86.95
Total assets	$235.6B
Total cash	$21.5B
Total debt	$56B
Total liabilities	$156.1B
WACC	7.09%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.43
Current ratio	0.74
Net working capital	$-38B
Quick ratio	0.42
Working capital	$-22.8B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.98%
Dividend growth	5.1%
Dividend growth (10Y)	28.29%
Dividend growth (3Y)	8.67%
Dividend growth (5Y)	10.9%
Dividend growth years	8
Dividend payment date	2026-09-22
Dividend payment years	9
Dividend payout frequency	Quarterly
Dividend per share	$6.98
Dividend yield	2.25%
Ex-dividend date	2026-09-14
Last dividend	$2.32
Payout ratio	51.45%
Shareholder yield	3.24%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$385.69
1D price change	0.41%
1M price change	9.23%
1M total return	9.23%
1W price change	-2.24%
1W total return	-2.24%
1Y price change	12.33%
1Y return CAGR	15.33%
1Y total return	15.32%
20-day SMA	$394.61
200-day SMA	$362.80
3M price change	-1.74%
3M total return	-1.13%
3Y price change	-21.64%
3Y return CAGR	-5.87%
3Y total return	-16.6%
50-day SMA	$389.73
50-day SMA vs 200-day SMA	50over200
52-week high	$461.00
52-week high date	2026-07-16
52-week low	$254.75
52-week low date	2026-03-30
5Y price change	-9.49%
5Y return CAGR	-0.2%
5Y total return	-0.98%
6M price change	16.75%
6M total return	18.14%
All-time high	$630.07
All-time high date	2024-11-11
All-time low	$193.80
All-time low date	2020-03-23
Average true range (ATR)	$13.04
Average volume	7.3K
Beta (5Y)	0.62
Change from 52-week high	-10.48%
Change from 52-week low	61.99%
Change from all-time high	-34.77%
Change from all-time low	112.07%
Change from open	1.05%
Day's gap	-0.64%
Dollar volume	$1.8M
High price	$416.27
Low price	$404.92
Monthly RSI	51.55
Open price	$408.38
Position in 52-week range	68.28%
Previous close	$410.99
Price vs 150-day SMA	6.56%
Price vs 20-day SMA	4.15%
Price vs 200-day SMA	13.28%
Price vs 50-day SMA	5.46%
Relative volume	0.61
RSI	59.66
Sharpe ratio	0.49
Sharpe ratio (3Y)	0.07
Sharpe ratio (5Y)	0.15
Sortino ratio	0.84
Sortino ratio (3Y)	0.2
Sortino ratio (5Y)	0.33
Volume	4.3K
Weekly RSI	60.04
YTD price change	24%
YTD total return	26.45%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	895M
Shares change (QoQ)	-0.44%
Shares change (YoY)	-0.98%
Shares held by insiders	0.17%
Shares held by institutions	88.98%
Short ratio	2.8 days

Deeper analysis on LON/0R0O

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this LON/0R0O report

Is a complete LON/0R0O research report available?

No complete published report is available for lon/0R0O (LON/0R0O) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

278.4B

Revenue (ttm)

339B

Net income (ttm)

12B

EPS (ttm)

$13.2

P/E (trailing)

23.6x

P/E (forward)

18.3x

Dividend

$6.98 (2.25%)

Volume

4,348

Beta

0.61

Metric

Value

Amount currency

GBP

Country

United States

Country code

Earnings date

2026-10-13

Employees

390,000

Employees change

-40,000

Employees growth

-9.09%

Enterprise value

$315.9B

Exchange

London Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-05-10

Fiscal year end

December

Founded

1974

Industry

Healthcare Plans

Is primary listing

ISIN number

US91324P1021

Last earnings date

2026-10-13

Last refreshed

2026-10-28

Market cap

$278.4B

Next earnings date

2027-01-12

Price

$412.67

Price currency

USD

Sector

Healthcare

SIC code

6324

Stock price date

2026-10-28

Symbol

lon/0R0O

Website

https://www.unitedhealthgroup.com

Metric

Value

Average P/E ratio (10Y)

22.39x

Average P/E ratio (3Y)

25.01x

Average P/E ratio (5Y)

24.72x

Earnings yield

4.24%

EV/Earnings

26.27x

EV/EBIT

15.88x

EV/EBITDA

13.71x

EV/FCF

18.28x

EV/Sales

0.93x

FCF / EV yield

5.47%

FCF yield

6.21%

Forward P/E

18.28x

Graham number

217.19437

Graham upside

-47.15%

Lynch fair value

$88.82

Lynch upside

-78.39%

P/(FCF - SBC) ratio

16.85x

P/(OCF - SBC) ratio

14.6x

P/B ratio

3.48x

P/E ratio

23.59x

P/FCF ratio

16.1x

P/OCF ratio

14.03x

P/S ratio

0.82x

Price / tangible book value

3.53x

Price/EBITDA ratio

12.72x

Sector forward P/E

14.52x

Sector P/E

22.58x

Metric

Value

EBIT margin

5.85%

EBITDA margin

6.42%

Effective tax rate

15.54%

FCF margin

5.08%

Gross margin

20.05%

Operating margin

5.85%

Pretax margin

4.38%

Profit margin

3.53%

Profit per employee

$30,678

Profitable quarters

Profitable years

Revenue per employee

$869,225

ROA

5.24%

ROA (5Y)

6.86%

ROCE

13.38%

ROE

15.77%

ROE (5Y)

20.42%

ROIC

12.39%

ROIC (5Y)

14.86%

SBC / revenue

0.23%

Tax / revenue

0.68%

Metric

Value

EPS growth

-8.96%

EPS growth (Q)

75.93%

EPS growth (QoQ)

-24.56%

EPS growth 10Y

9.96%

EPS growth 3Y

-8.76%

EPS growth 5Y

1.66%

EPS growth quarters

EPS growth years

FCF growth

31.4%

FCF growth (Q)

-15.65%

FCF growth (QoQ)

-58.41%

FCF growth 3Y

-4.78%

FCF growth 5Y

-0.06%

Net income growth

-9.69%

Net income growth (Q)

75.04%

Net income growth (QoQ)

-25.05%

Net income growth 3Y

-9.86%

Net income growth 5Y

0.59%

Net income growth quarters

Net income growth years

OCF growth

24.99%

OCF growth (Q)

-13.83%

OCF growth (QoQ)

-53.65%

OCF growth 10Y

5.94%

OCF growth 3Y

-4.13%

OCF growth 5Y

0.76%

Revenue growth

3.42%

Revenue growth (Q)

-0.41%

Revenue growth (QoQ)

0.59%

Revenue growth 10Y

9.54%

Revenue growth 3Y

7.73%

Revenue growth 5Y

10.01%

Revenue growth quarters

126

Revenue growth years

Metric

Value

Capital expenditures

$-2.5B

EBIT

$19.8B

EBITDA

$21.8B

EPS

$13.17

Financing cash flow

$-12.1B

Free cash flow

$17.2B

Free cash flow minus SBC

$16.4B

Gross profit

$68B

Income taxes

$2.3B

Investing cash flow

$-8.6B

Net borrowing

$-3.6B

Net cash flow

$-1B

Net income

$12B

Operating cash flow minus SBC

$19B

Operating income

$19.8B

Revenue

$339B

Stock-based compensation

$767.5M

Metric

Value

Book value per share

$86.95

Debt / EBITDA

2.44

Debt / equity

0.7

Debt / FCF

3.26

Interest coverage

6.84

Net cash (debt)

$-36.5B

Net cash / market cap

-13.19%

Net debt / EBITDA

1.68

Net debt / equity

0.46

Net debt / FCF

2.12

Piotroski F-Score

Shareholders' equity

$79.5B

Tangible book value

$78.4B

Tangible book value per share

$86.95

Total assets

$235.6B

Total cash

$21.5B

Total debt

$56B

Total liabilities

$156.1B

WACC

7.09%

Metric

Value

Asset turnover

1.43

Current ratio

0.74

Net working capital

$-38B

Quick ratio

0.42

Working capital

$-22.8B

Metric

Value

Buyback yield / dilution

0.98%

Dividend growth

5.1%

Dividend growth (10Y)

28.29%

Dividend growth (3Y)

8.67%

Dividend growth (5Y)

10.9%

Dividend growth years

Dividend payment date

2026-09-22

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

$6.98

Dividend yield

2.25%

Ex-dividend date

2026-09-14

Last dividend

$2.32

Payout ratio

51.45%

Shareholder yield

3.24%

Metric

Value

150-day SMA

$385.69

1D price change

0.41%

1M price change

9.23%

1M total return

9.23%

1W price change

-2.24%

1W total return

-2.24%

1Y price change

12.33%

1Y return CAGR

15.33%

1Y total return

15.32%

20-day SMA

$394.61

200-day SMA

$362.80

3M price change

-1.74%

3M total return

-1.13%

3Y price change

-21.64%

3Y return CAGR

-5.87%

3Y total return

-16.6%

50-day SMA

$389.73

50-day SMA vs 200-day SMA

50over200

52-week high

$461.00

52-week high date

2026-07-16

52-week low

$254.75

52-week low date

2026-03-30

5Y price change

-9.49%

5Y return CAGR

-0.2%

5Y total return

-0.98%

6M price change

16.75%

6M total return

18.14%

All-time high

$630.07

All-time high date

2024-11-11

All-time low

$193.80

All-time low date

2020-03-23

Average true range (ATR)

$13.04

Average volume

7.3K

Beta (5Y)

0.62

Change from 52-week high

-10.48%

Change from 52-week low

61.99%

Change from all-time high

-34.77%

Change from all-time low

112.07%

Change from open

1.05%

Day's gap

-0.64%

Dollar volume

$1.8M

High price

$416.27

Low price

$404.92

Monthly RSI

51.55

Open price

$408.38

Position in 52-week range

68.28%

Previous close

$410.99

Price vs 150-day SMA

6.56%

Price vs 20-day SMA

4.15%

Price vs 200-day SMA

13.28%

Price vs 50-day SMA

5.46%

Relative volume

0.61

RSI

59.66

Sharpe ratio

0.49

Sharpe ratio (3Y)

0.07

Sharpe ratio (5Y)

0.15

Sortino ratio

0.84

Sortino ratio (3Y)

0.2

Sortino ratio (5Y)

0.33

Volume

4.3K

Weekly RSI

60.04

YTD price change

24%

YTD total return

26.45%

Metric

Value

Float

895M

Shares change (QoQ)

-0.44%

Shares change (YoY)

-0.98%

Shares held by insiders

0.17%

Shares held by institutions

88.98%

Short ratio

2.8 days

LON/0R0O (LON/0R0O)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0R0O

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0R0O indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0R0O

Frequently asked questions

LON/0R0O (LON/0R0O)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0R0O

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0R0O indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0R0O

Frequently asked questions